Biopharmaceutical companies have been struggling since 2021 and that narrative isn’t immediately changing. However, not every firm deserves this fate. In fact, investors can find great opportunities with “cheap” biotech stocks to buy now. There are many reasons for investor pessimism that could soon ease. For instance, drug innovation has stagnated in 2022. Companies also
Stocks to buy
If you’re a grandparent — or if you aspire to be one, at some point — one of the best gifts you can give your youngest family members is a firm financial foundation. While part of that could be an inheritance, it’s also important to teach the little tykes how grandma and grandpa managed to